| Literature DB >> 31565899 |
Gang San Kim1, Tae Sik Kim1, Joo Sung Son1, Van Dam Lai1, Jung Eun Park2, Seung Jun Wang2, Weon Hwa Jheong2, In Pil Mo3.
Abstract
Korea is located within the East Asian-Australian flyway of wild migratory birds during the fall and winter seasons. Consequently, the likelihood of introduction of numerous subtypes and pathotypes of the Avian influenza (AI) virus to Korea has been thought to be very high. In the current study, we surveyed wild bird feces for the presence of AI virus that had been introduced to Korea between September 2017 and February 2018. To identify and characterize the AI virus, we employed commonly used methods, namely, virus isolation (VI) via egg inoculation, real-time reverse transcription-polymerase chain reaction (rRT-PCR), conventional RT-PCR (cRT-PCR) and a newly developed next generation sequencing (NGS) approach. In this study, 124 out of 11,145 fresh samples of wild migratory birds tested were rRT-PCR positive; only 52.0% of VI positive samples were determined as positive by rRT-PCR from fecal supernatant. Fifty AI virus specimens were isolated from fresh fecal samples and typed. The cRT-PCR subtyping results mostly coincided with the NGS results, although NGS detected the presence of 11 HA genes and four NA genes that were not detected by cRT-PCR. NGS analysis confirmed that 12% of the identified viruses were mixed-subtypes which were not detected by cRT-PCR. Prevention of the occurrence of AI virus requires a workflow for rapid and accurate virus detection and verification. However, conventional methods of detection have some limitations. Therefore, different methods should be combined for optimal surveillance, and further studies are needed in aspect of the introduction and application of new methods such as NGS.Entities:
Keywords: Avian influenza; Korea; conventional method; next generation sequencing; wild bird
Mesh:
Year: 2019 PMID: 31565899 PMCID: PMC6769331 DOI: 10.4142/jvs.2019.20.e56
Source DB: PubMed Journal: J Vet Sci ISSN: 1229-845X Impact factor: 1.672
Primer sets used for AI virus identification and analysis
| Application | Target gene | Primer | Sequences* (5′–3′) | Reference |
|---|---|---|---|---|
| rRT-PCR | MA | M+25 | AGATGAGTCTTCTAACCGAGGTCG | [ |
| M-124 | TGCAAAAACATCTTCAAGTCTCTG | |||
| M+64 | FAM-TCAGGCCCCCTCAAAGCCGA-TAMRA | |||
| AI identification | NP | NP1200 | CAG(A/G)TACTGGGC(A/T/C)ATAAG(A/G)AC | [ |
| NP1529 | GCATTGTCTCCGAAGAAATAAG | |||
| MA | M52C | CTTCTAACCGAGGTCGAAACG | [ | |
| M253R | AGGGCATTTTGGACAAAKCGTCTA | |||
| NGS preparation | cDNA | MBTuni-12 | ACGCGTGATCAGCAAAAGCAGG | [ |
| MBTuni-13 | ACGCGTGATCAGTAGAAACAAGG | |||
| Subtyping | NA | N1-F | AGRCCTTGYTTCTGGGTTGA | [ |
| N1-R | ACCGTCTGGCCAAGACCA | |||
| N2-F | GCATGGTCCAGYTCAAGYTG | |||
| N2-R | CCYTTCCAGTTGTCTCTGCA | |||
| N3-F | AGATCRGGCTTTGAARTCATCAAAGT | |||
| N3-R | CATTGTCTARTCCACAGAAAGTAACTATAC | |||
| N4-F | TGGATAAGATTCAACAGTGA | |||
| N4-R | GGTATCAGAATTAACACCACA | |||
| N5-F | GTTATTGGGTAATGACRGAYGGTC | |||
| N5-R | GGTCTATTCATTCCATTCCAA | |||
| N6-F | GCIACAGGAATGACACTATC | |||
| N6-R | GRATGTGCCATGARTTTA C | |||
| N7-F | GTYGACAAYAACAATTGGTCAGG | |||
| N7-R | CCCAACTGRGAITGGGCT | |||
| N8-F | GGTCAGGATAYAGYGGTTCYTTCAC | |||
| N8-R | CCACACATCACAATGGAGCT | |||
| N9-F | AACACIGACTGGAGTGGYTAC | |||
| N9-R | GGAATTCTGTRCTGGAACAC | |||
| HA | H1-550F | AACAAYAARGRGAAAGAAGT | [ | |
| H1-1016R | GGGACDTTYCTTARTCCTGT | |||
| H2-422F | GAGAAARTWAAGATTCTGCC | |||
| H2-1083R | CCAAACAAYCCYCTTGAYTC | |||
| H3-175F | CARATTGARGTGACHAATGC | |||
| H3-896R | GGTGCATCTGAYCTCATTA | |||
| H4-8F | GCAGGGGAAACAATGCTATC | |||
| H4-777R | CCWGGYTCTACAATWGTCC | |||
| H5-155F | ACACATGCYCARGACATACT | |||
| H5-699R | CTYTGRTTYAGTGTTGATGT | |||
| H6-661F | AGCATGAATTTTGCCAAGAG | |||
| H6-962R | GGRCATTCTCCTATCCACAG | |||
| H7-12F | GGGATACAAAATGAAYACTC | |||
| H7-645R | CCATABARYYTRGTCTGYTC | |||
| H8-166F | GTGGAAACAGAGAAACAT | |||
| H8-597R | CCATAAGAARATGATGTCT | |||
| H9-151F | CTYCACACAGARCACAATGG | |||
| H9-638R | GTCACACTTGTTGTTGTRTC | |||
| H10-521F | GGACAAAAYTTCCCTCAGAC | |||
| H10-932R | GRAAAGGGAGCTTTGTATTT | |||
| H11-240F | TGYTCMTTTGCTGGRTGGAT | |||
| H11-689R | CTCTGAACCCACTGCTACAT | |||
| H12-11F | AGGGGTCACAATGGAAAAA | |||
| H12-431R | GGTGAAATCAAACATCTTCA | |||
| H13-203F | CCACACAGGAACATAYTGTTC | |||
| H13-433R | CTACTGAAWGAYCTGATTCC | |||
| H14-444F | TCATCGCCGAACAATTCACC | |||
| H14-986R | GCAGTTTCCTATAGCAATCC | |||
| H15-455F | GTGCGTGTAAGAGAACAGTG | |||
| H15-837R | ATTAGAGCGGAGAAAGGTGG | |||
| H12-11F | AGGGGTCACAATGGAAAAA | |||
| H12-431R | GGTGAAATCAAACATCTTCA | |||
| H13-203F | CCACACAGGAACATAYTGTTC | |||
| H13-433R | CTACTGAAWGAYCTGATTCC | |||
| H14-444F | TCATCGCCGAACAATTCACC | |||
| H14-986R | GCAGTTTCCTATAGCAATCC | |||
| H15-455F | GTGCGTGTAAGAGAACAGTG | |||
| H15-837R | ATTAGAGCGGAGAAAGGTGG |
AI, avian influenza; rRT-PCR, real-time reverse transcription-polymerase chain reaction; MA, matrix protein; NP, nucleoprotein; NGS, next generation sequencing; NA, neuraminidase; HA, hemagglutinin.
*FAM, 6-carboxyfluorescein; TAMRA, 6-carboxytetramethylrhodamine; BHQ, Biblia Hebraica Quinta.
AI virus identification, isolation, and subtyping using different methods*
| Sample No. | rRT-PCR | VI | cRT-PCR | NGS | |
|---|---|---|---|---|---|
| CE1 | CE2 | ||||
| 1 | Pos | − | + | H11? | H11N3 |
| 2 | Pos | + | + | H4N6 | H4N6 |
| 3 | Pos | + | + | H6N2 | H6N2 |
| 4 | Pos | + | + | ?N1 | H2N1 |
| 5 | Pos | + | + | ?N2 | H9N2 |
| 6 | Pos | + | + | H6N2 | H6N2 |
| 7 | Pos | + | + | ?N8 | H3N8 |
| 8 | Pos | + | + | ?N3 | H1N3 |
| 9 | Pos | − | + | ?N1 | H1N1, H7N1 |
| 10 | Pos | + | + | H9N2 | H9N2 |
| 11 | Pos | + | + | H3N8 | H3N8 |
| 12 | Pos | + | + | H1N1 | H1N1 |
| 13 | Neg | + | + | H3N8 | H3N8 |
| 14 | Neg | + | + | ?N1 | H1N1, H7N1 |
| 15 | Neg | + | + | ?N1 | H1N1 |
| 16 | Pos | + | + | H1N1 | H1N1 |
| 17 | Pos | + | + | H3N8 | H3N8 |
| 18 | Pos | + | + | H6N2 | H6N2 |
| 19 | Neg | − | + | H3N6 | H3N6 |
| 20 | Neg | + | + | H2? | H2N7 |
| 21 | Pos | − | + | H11N9 | H11N9 |
| 22 | Pos | + | + | H11N3 | H11N3 |
| 23 | Pos | + | + | H1N1 | H1N1, H7N1 |
| 24 | Pos | − | + | H1N1 | H1N1, H7N1 |
| 25 | Neg | − | + | H1N1 | H1N1 |
| 26 | Neg | − | + | H1N1 | H1N1 |
| 27 | Neg | − | + | H1N1 | H1N1 |
| 28 | Neg | + | + | ?N3 | H1N3 |
| 29 | Neg | + | + | ?N1 | H2N1 |
| 30 | Neg | − | + | H6N8 | H6N8 |
| 31 | Neg | + | + | H4N6 | H4N6 |
| 32 | Neg | − | + | H3N8 | H3N8 |
| 33 | Neg | + | + | H4N6 | H4N6 |
| 34 | Neg | + | + | H11N9 | H11N9 |
| 35 | Pos | + | + | H1N1 | H1N1 |
| 36 | Pos | − | + | N/A | H1N1 |
| 37 | Neg | + | + | H1N1 | H1N1 |
| 38 | Pos | + | + | H11N? | H11N9 |
| 39 | Pos | + | + | H6N1 | H6? |
| 40 | Neg | + | + | H3N2 | H3N2, H3N8 |
| 41 | Neg | + | + | ?N3 | H1N3 |
| 42 | Neg | + | + | H6N2 | H6N2 |
| 43 | Pos | + | + | H10N5 | H10N5 |
| 44 | Neg | + | + | H3N8 | H3N8 |
| 45 | Pos | − | + | H5N2 | H5N2 |
| 46 | Neg | + | + | H3N8 | H3N8 |
| 47 | Neg | + | + | H4N1 | H4N1 |
| 48 | Neg | + | + | H4N1 | H4N1 |
| 49 | Pos | + | + | H1N1 | H1N1 |
| 50 | Neg | + | + | H3N8 | H3N2, H3N8 |
AI, avian influenza; rRT-PCR, real-time reverse transcription-polymerase chain reaction; VI, virus isolation; CE, chicken embryo; cRT-PCR, conventional reverse transcription-polymerase chain reaction; NGS, next generation sequencing.
*A rRT-PCR CT value below 40 indicates a positive reaction (Pos) and negative reaction (Neg); Question marks denote uncertainty of identification; Specimen No. 9 contained H1 (1,776 bp, 38,994 reads) and H7 (1,663 bp, 336 reads); No. 14 contained H1 (1,554 bp, 40,047 reads) and H7 (1,345 bp, 498 reads); No. 23 contained H1 (1,777 bp, 34,024 reads) and H7 (1,729 bp, 376 reads); and No. 24 contained H1 (1,784 bp, 24,110 reads) and H7 (1,728 bp, 234 reads).
Match rate of the subtyping results obtained by cRT-PCR and NGS*
| Subtype | cRT-PCR (%) | NGS (%) |
|---|---|---|
| H1 | 10/17 (58.8) | 17/17 (100.0) |
| H2 | 1/3 (33.3) | 3/3 (100.0) |
| H3 | 9/10 (90.0) | 10/10 (100.0) |
| H4 | 5/5 (100.0) | 5/5 (100.0) |
| H5 | 1/1 (100.0) | 1/1 (100.0) |
| H6 | 6/6 (100.0) | 6/6 (100.0) |
| H7 | 0/4 (0.0) | 4/4 (100.0) |
| H9 | 1/2 (50.0) | 2/2 (100.0) |
| H10 | 1/1 (100.0) | 1/1 (100.0) |
| H11 | 5/5 (100.0) | 5/5 (100.0) |
| N1 | 19/20 (95.0) | 19/20 (95.0) |
| N2 | 7/9 (77.8) | 9/9 (100.0) |
| N3 | 4/5 (80.0) | 5/5 (100.0) |
| N5 | 1/1 (100.0) | 1/1 (100.0) |
| N6 | 4/4 (100.0) | 4/4 (100.0) |
| N7 | 0/1 (0.0) | 1/1 (100.0) |
| N8 | 9/9 (100.0) | 9/9 (100.0) |
| N9 | 2/3 (66.7) | 3/3 (100.0) |
cRT-PCR, conventional reverse transcription-polymerase chain reaction; NGS, next generation sequencing.
*The numerator indicates the number of correct matches for each method and the denominator is the number of each subtype segment identified by cRT-PCR and NGS.
The average value of BOC and DOC for NGS characterization of the influenza genome*
| Gene segment (bp) | Contig | Average BOC (%) | Average DOC |
|---|---|---|---|
| PB2 (2,341) | 50 | 84.6 | 18,211.2 |
| PB1 (2,341) | 51 | 88.1 | 12,973.1 |
| PA (2,341) | 51 | 83.8 | 19,279.1 |
| HA (1,779) | 54 | 96.3 | 27,032.2 |
| NP (1,565) | 47 | 95.0 | 34,300 |
| NA (1,413) | 52 | 94.0 | 27,543.3 |
| MA (1,027) | 52 | 94.2 | 60,786.5 |
| NS (890) | 46 | 95.9 | 50,149.9 |
| Whole genome (13,588) | 403 | 91.1 | 23,030.5 |
BOC, breadth of sequence coverage; DOC, depth of coverage; NGS, next generation sequencing.
*The BOC was calculated as sequence percentage of actual testing contig length divided by the theoretical genome length; The DOC was the BOC multiplied by the read counts; a the numbers denotes the representative lengths of each segments from AI virus (A/Puerto Rico/8/1934[H1N1]).